1-6 of 6
Lisa l Wood, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Praveen Ranganath, MBBS, Michael J. Robertson, MD, Rafat Abonour, MD, Jennifer E. Schwartz, MD FRCP(C), Sherif Farag, MBBS, PhD, Lisa l Wood, RN, Patrick Kiel, PharmD, Robert Nelson
Journal: Blood
Blood (2014) 124 (21): 5874.
https://doi.org/10.1182/blood.V124.21.5874.5874
Published: 2014
Journal Articles

A Phase I/II Trial Combining High-Dose Lenalidomide with Melphalan and Autologous Transplant for Multiple Myeloma: A Report of the Phase I Dose-Finding Study.

Attaya Suvannasankha, MD, Sherif Farag, MD, PhD, FRACP, FRCPA, Rebecca Silbermann, M.D., Robin Obryant, RN, Lisa l Wood, RN, Abigail Huljak, Angie Secrest, Colin D. Crean, Rafat Abonour, MD
Journal: Blood
Blood (2012) 120 (21): 3146.
https://doi.org/10.1182/blood.V120.21.3146.3146
Published: 2012
Journal Articles

Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients

Attaya Suvannasankha, Sherif Farag, MD, PhD, FRACP, FRCPA, Robin Obryant, RN, Lisa l Wood, RN, Nicole Porter, Rafat Abonour, MD
Journal: Blood
Blood (2010) 116 (21): 1970.
https://doi.org/10.1182/blood.V116.21.1970.1970
Published: 2010
Journal Articles

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma.

Sherif Farag, MD, PhD, Lisa L Wood, RN, Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Jennifer E. Schwartz, MD, FRCP(C), Elizabeth Cox, Rafat Abonour, MD, Michael Robertson, MD,
Journal: Blood
Blood (2009) 114 (22): 3402.
https://doi.org/10.1182/blood.V114.22.3402.3402
Published: 2009
Journal Articles

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia.

Sherif Farag, MD, PhD, Lisa L Wood, RN, Jennifer E. Schwartz, MD, FRCP(C), Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Michael Robertson, MD, Rafat Abonour, MD, Hamid Sayar, MD, Larry D. Cripe, MD
Journal: Blood
Blood (2009) 114 (22): 198.
https://doi.org/10.1182/blood.V114.22.198.198
Published: 2009
Journal Articles

Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients.

Attaya Suvannasankha, MD, Sherif Farag, MBBS, PhD, Robin A O'Bryant, RN, Lisa L Wood, RN, Rafat Abonour
Journal: Blood
Blood (2009) 114 (22): 2882.
https://doi.org/10.1182/blood.V114.22.2882.2882
Published: 2009